Treatment of Reye syndrome

Annals of Neurology
D A Trauner

Abstract

Although the underlying cause of Reye syndrome is not understood, an effective approach to treatment is based on reversing the known metabolic and pathological abnormalities. A multifaceted therapeutic approach aimed at correcting metabolic derangements and combating intracranial hypertension can result in complete recovery from severe cases of Reye syndrome.

References

Sep 1, 1978·Neurology·D A Trauner, P R Huttenlocher
Sep 1, 1977·Annals of Neurology·D TraunerW L Nyhan
Jan 1, 1978·Critical Care Medicine·L F MarshallN M Kaufman
Sep 1, 1978·Annals of Neurology·D A TraunerP R Huttenlocher
Mar 1, 1975·Neurology·D A TraunerL Sweetman
Dec 1, 1975·The Journal of Pediatrics·D C DeVivoM W Haymond
Mar 1, 1974·The Journal of Pediatrics·M D HiltyP V Delamater
Dec 9, 1971·The New England Journal of Medicine·J C PartinJ S Partin
Nov 1, 1965·American Journal of Diseases of Children·M F Randolph, M Greenfield
Nov 1, 1956·The Journal of Clinical Investigation·D R DAHLF E SAMSON
Nov 14, 1964·Lancet·H L UTIANR J SICHEL

❮ Previous
Next ❯

Citations

Apr 1, 1988·Journal of Neurosurgery·G H BarnettJ Romeo
Dec 1, 1980·Biochemical Medicine·C Bhuvaneswaran, M A Brewster
Nov 1, 1981·Anaesthesia and Intensive Care·R F JonesT A Torda
Nov 1, 1982·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·D L KeeneJ P Fletcher
Jun 1, 1996·Neurology·B E ShapiroD C Preston
Aug 1, 1980·Annals of Neurology·L G Tomasi
Jun 1, 1987·The Journal of Pediatrics·T C Frewen, N Kissoon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.